Both cardiomyocyte and endothelial cell Nox4 mediate protection against hemodynamic overload-induced remodelling

Min Zhang1, Heloise Mongue-Din1, Daniel Martin1

  • 1Cardiovascular Division, James Black Centre, King's College London British Heart Foundation Centre of Excellence, 125 Coldharbour Lane, London SE5 9NU, UK.

Cardiovascular Research
|October 18, 2017
PubMed
Abstract

Insights

NADPH oxidase-4 (Nox4) protects the heart from pressure overload. Both cardiomyocyte and endothelial cell Nox4 are crucial for maintaining myocardial capillary density and preventing cardiac remodeling.

Area of Science:

  • Cardiovascular Biology
  • Oxidative Stress Research
  • Cardiac Physiology

Background:

  • NADPH oxidase-4 (Nox4) is a key source of reactive oxygen species (ROS) in the heart, upregulated during hemodynamic overload.
  • Previous studies on Nox4 knockout (Nox4KO) mice yielded conflicting results regarding its role in cardiac pressure overload models.
  • Divergent outcomes may stem from cell-specific Nox4 functions or variations in pressure overload models (abdominal aortic banding vs. transverse aortic constriction).

Purpose of the Study:

  • To investigate if Nox4's impact on cardiac remodeling differs between pressure overload models.
  • To compare the specific roles of Nox4 in cardiomyocytes versus endothelial cells during cardiac stress.

Main Methods:

  • Global Nox4 knockout (Nox4KO) mice were subjected to transverse aortic constriction (TAC).
  • Inducible cardiomyocyte-specific Nox4 KO (Cardio-Nox4KO) and endothelial-specific Nox4 KO (Endo-Nox4KO) mice were generated and subjected to pressure overload.
  • Cardiac remodeling, contractile function, HIF1α, VEGF protein levels, and myocardial capillarization were assessed.

Main Results:

  • Global Nox4KO mice exhibited exacerbated cardiac remodeling and dysfunction post-TAC, mirroring previous findings.
  • Both Cardio-Nox4KO and Endo-Nox4KO mice showed worsened cardiac remodeling and dysfunction compared to wild-type controls.
  • These detrimental effects were associated with decreased HIF1α and VEGF levels and impaired myocardial capillarization.

Conclusions:

  • Both cardiomyocyte and endothelial cell Nox4 play protective roles against chronic hemodynamic overload.
  • Nox4's protective effects are, at least partly, mediated by maintaining myocardial capillary density.
  • These findings clarify the cell-specific contributions of Nox4 in cardiac pressure overload.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...